Clinical Trial Update: Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients [Phase 1]

View source ↗

Summary

This Phase 1 study evaluates the pharmacokinetics and preliminary bioequivalence of ferric pyrophosphate citrate (Triferic) when administered via hemodialysate …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• Triferic (ferric pyrophosphate)

Snippet

Sponsor: Rockwell Medical Technologies, Inc. | Conditions: End Stage Renal Disease | Phase 1 | Status: COMPLETED | Results posted: 2019-02-01